Vaccines - United Kingdom (Related Reports)

Vaccines - United Kingdom


April 18, 2011
SKU: GRDS6631232
License type:
PDF E-mail From Publisher      US $654.00
Vaccines: The End of Illness Overview
4/10/2014 | published by: CHI Insight Pharma Reports
Vaccines: The End of Illness Overview New to Insight Pharma Reports is Vaccines: The End of Illness. This report focuses on the most recent vaccine research, emphasizing  |  read more...
$2,495.00
Global Therapeutic Vaccines Market 2014-2018
3/28/2014 | published by: Infiniti Research Limited - TechNavio
Global Therapeutic Vaccines Market 2014-2018 About Therapeutic Vaccines A therapeutic vaccine is a biological combination developed to improve immunity by inducing an attack against a diseased cell or tissue. This differs from prophylactic vaccines, which are administered  |  read more...
$2,500.00
Cancer Vaccines Drug Pipeline Update 2014
3/25/2014 | published by: BioSeeker Group AB
Cancer Vaccines Drug Pipeline Update 2014 Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite years of R&D, a reproducible survival benefit has proved elusive, leaving  |  read more...
$5,622.50
Competitor Analysis: Cancer Vaccines
3/24/2014 | published by: La Merie Publishing
Cancer Vaccines The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines to fight cancer as of March 2014. Purchase of  |  read more...
$1,112.00
Analytical Tool - Cancer Vaccines
3/25/2014 | published by: BioSeeker Group AB
Analytical Tool - Cancer Vaccines Analytical Tool - Cancer Vaccines offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer vaccine drug development. It is at the same time  |  read more...
$11,625.00
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Current and Future Players
1/31/2014 | published by: GlobalData
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Current and Future Players”. The report is a vital source of up-to-date  |  read more...
$2,995.00
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - US Drug Forecast and Market Analysis to 2022
1/31/2014 | published by: GlobalData
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - US Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver.  |  read more...
$4,995.00
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Canada Drug Forecast and Market Analysis to 2022
1/31/2014 | published by: GlobalData
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Canada Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver.  |  read more...
$4,995.00
Ambirix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022
1/31/2014 | published by: GlobalData
Ambirix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and  |  read more...
$3,495.00
Bimmugen (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022
1/31/2014 | published by: GlobalData
Bimmugen (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and  |  read more...
$3,495.00
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!